APA (7th ed.) Citation

Ronald Palmen, Ronald Palmen, Ronald Palmen, Tracy Sandritter, Tracy Sandritter, Lindsey Malloy-Walton, . . . Jonathan B. Wagner. (2023). Case report: Use of therapeutic drug monitoring and pharmacogenetic testing as opportunities to individualize care in a case of flecainide toxicity after fetal supraventricular tachycardia. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Ronald Palmen, et al. Case Report: Use of Therapeutic Drug Monitoring and Pharmacogenetic Testing as Opportunities to Individualize Care in a Case of Flecainide Toxicity After Fetal Supraventricular Tachycardia. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Ronald Palmen, et al. Case Report: Use of Therapeutic Drug Monitoring and Pharmacogenetic Testing as Opportunities to Individualize Care in a Case of Flecainide Toxicity After Fetal Supraventricular Tachycardia. Frontiers Media S.A., 2023.